MedPath

University of Regensburg

University of Regensburg logo
🇩🇪Germany
Ownership
Private
Established
1962-01-01
Employees
1K
Market Cap
-
Website
http://www.uni-regensburg.de

Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients

Conditions
Subarachnoid Hemorrhage
First Posted Date
2011-02-09
Last Posted Date
2014-12-05
Lead Sponsor
University of Regensburg
Target Recruit Count
90
Registration Number
NCT01292278
Locations
🇩🇪

Department of Neurosurgery Medical Center University of Regensburg, Regensburg, Germany

Combined Low Frequency Frontal and Temporal rTMS Treatment in Chronic Tinnitus

Not Applicable
Completed
Conditions
Tinnitus
Interventions
Device: Temporal low frequency rTMS
Device: Combined frontal and temporal rTMS
First Posted Date
2010-12-17
Last Posted Date
2016-01-08
Lead Sponsor
University of Regensburg
Target Recruit Count
50
Registration Number
NCT01261949
Locations
🇩🇪

University of Regensburg - Dept of Psychiatry, Regensburg, Bayern, Germany

Effectiveness of Theta-burst Stimulation (TBS) in Patients With Major Depression

Not Applicable
Completed
Conditions
Depression
Interventions
Device: Thetaburst Stimulation
Device: High frequency rTMS
Device: Placebo Stimulation
First Posted Date
2010-11-15
Last Posted Date
2013-10-16
Lead Sponsor
University of Regensburg
Target Recruit Count
61
Registration Number
NCT01240083
Locations
🇩🇪

University of Regensburg- Dept of Psychiatry, Regensburg, Bavaria, Germany

Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty

Phase 3
Completed
Conditions
Perioperative Blood Loss
Arthroplasties Hip Replacement
Coxarthrosis
Interventions
First Posted Date
2010-10-28
Last Posted Date
2014-09-15
Lead Sponsor
University of Regensburg
Target Recruit Count
100
Registration Number
NCT01229774
Locations
🇩🇪

Department of Orthopedic Surgery, Bad Abbach, Bavaria, Germany

CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation

Phase 2
Conditions
Renal Impairment
Liver Transplantation
Everolimus
Interventions
Drug: delayed, low-dose CNI
Drug: BU-CNI
Drug: BU-Everolimus
First Posted Date
2009-12-02
Last Posted Date
2011-07-01
Lead Sponsor
University of Regensburg
Target Recruit Count
45
Registration Number
NCT01023542
Locations
🇩🇪

Regensburg University Hospital, Regensburg, Bavaria, Germany

Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial

Phase 1
Conditions
Multiple Myeloma
First Posted Date
2009-11-09
Last Posted Date
2012-05-30
Lead Sponsor
University of Regensburg
Target Recruit Count
54
Registration Number
NCT01010243
Locations
🇩🇪

Schön Klinik Starnberger See, Berg, Germany

🇩🇪

Klinikum d. Universität München, Med. Klinik u. Poliklinik IV, Abt. H/O, München, Germany

🇩🇪

Gemeinschaftspraxis Hämato/Onkologie, München, Germany

and more 3 locations

Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

Phase 1
Completed
Conditions
Glioblastoma
Interventions
First Posted Date
2009-07-23
Last Posted Date
2009-07-23
Lead Sponsor
University of Regensburg
Target Recruit Count
63
Registration Number
NCT00944801
Locations
🇩🇪

University of Regensburg, Department of Neurology, Regensburg, Germany

Effectiveness Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Chronic Tinnitus

Not Applicable
Completed
Conditions
Tinnitus
Interventions
Device: rTMS - Intervention 1
Device: rTMS - Intervention 2
First Posted Date
2009-04-07
Last Posted Date
2010-11-15
Lead Sponsor
University of Regensburg
Target Recruit Count
100
Registration Number
NCT00876720
Locations
🇩🇪

University of Regensburg - Dept of Psychiatry, Regensburg, Bavaria, Germany

Muscle Tissue Oxygenation in Patients With Decompensated Liver Cirrhosis

Conditions
Liver Cirrhosis
First Posted Date
2009-02-24
Last Posted Date
2009-02-24
Lead Sponsor
University of Regensburg
Target Recruit Count
90
Registration Number
NCT00849641
Locations
🇩🇪

University Hospital of Regensburg, Regensburg, Germany

Etoricoxib in Ear Nose Throat Surgery

Phase 3
Conditions
Tonsillectomy
Interventions
Drug: Administration of placebo
Drug: Administration of etoricoxib
First Posted Date
2008-09-22
Last Posted Date
2008-09-22
Lead Sponsor
University of Regensburg
Target Recruit Count
90
Registration Number
NCT00756873
Locations
🇩🇪

Weiden Clinic, Weiden i.d. OPf., Germany

🇩🇪

Universtiy Hospital Regensburg, Regensburg, Germany

© Copyright 2025. All Rights Reserved by MedPath